Galectin Therapeutics (GALT) Accumulated Depreciation & Amortization (2011 - 2017)
Galectin Therapeutics' quarterly Accumulated Depreciation & Amortization came in at $1000.0 in Q4 2017, little changed quarter-over-quarter from $1000.0 in Q4 2015.
Galectin Therapeutics has reported Accumulated Depreciation & Amortization for 6 years, with the latest figure at $1000.0 in Q4 2017.
- For the quarter ending Q4 2017, Accumulated Depreciation & Amortization changed N/A year-over-year to $1000.0; the trailing twelve-month figure through Dec 2017 stood at $1000.0 (changed N/A YoY), and the FY2017 full-year result was $1000.0, changed N/A from the prior year.
- Accumulated Depreciation & Amortization for Q4 2017 stood at $1000.0, roughly flat from $1000.0 in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $3000.0 in Q4 2013, with the low at $1000.0 in Q4 2015.
- Average Accumulated Depreciation & Amortization over 4 years is $1750.0, with a median of $1500.0 recorded in 2014.
- Year-over-year, Accumulated Depreciation & Amortization changed 0.0% in 2013 and sank 50.0% in 2015.
- Tracing GALT's Accumulated Depreciation & Amortization over 4 years: stood at $3000.0 in 2013, then plunged by 33.33% to $2000.0 in 2014, then slumped by 50.0% to $1000.0 in 2015, then changed by 0.0% to $1000.0 in 2017.
- The last three Accumulated Depreciation & Amortization figures came in at $1000.0 (Q4 2017), $1000.0 (Q4 2015), and $2000.0 (Q4 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Dec 31, 2014 | 2,000.00 |
| Dec 31, 2014 | 2,000.00 |
| Dec 31, 2013 | 3,000.00 |
| Dec 31, 2013 | 3,000.00 |
| Dec 31, 2012 | 3,000.00 |
| Dec 31, 2012 | 3,000.00 |
| Dec 31, 2011 | 315,000.00 |
| Dec 31, 2011 | 315,000.00 |